Latest Insider Transactions at Oncorus, Inc. (ONCR)
This section provides a real-time view of insider transactions for Oncorus, Inc. (ONCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oncorus, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oncorus, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
138,872
-5.08%
|
$0
$0.27 P/Share
|
|
Dec 29
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
141,753
-4.93%
|
$0
$0.26 P/Share
|
|
Dec 28
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
55,610
-1.9%
|
$0
$0.25 P/Share
|
|
Dec 27
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
65,090
-2.17%
|
$0
$0.27 P/Share
|
|
Dec 22
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,294
-0.28%
|
$0
$0.28 P/Share
|
|
Dec 21
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,800
-0.46%
|
$0
$0.3 P/Share
|
|
Dec 20
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,740
-0.49%
|
$0
$0.31 P/Share
|
|
Dec 19
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
99,718
-3.18%
|
$0
$0.29 P/Share
|
|
Dec 15
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,089
-0.1%
|
$0
$0.39 P/Share
|
|
Dec 14
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,600
-0.27%
|
$0
$0.38 P/Share
|
|
Dec 13
2022
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,097
-0.07%
|
$0
$0.41 P/Share
|
|
May 25
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
3,777
+6.9%
|
$3,777
$1.2 P/Share
|
|
May 20
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
1,610
+3.3%
|
$1,610
$1.2 P/Share
|
|
May 19
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
5,000
+9.88%
|
$5,000
$1.29 P/Share
|
|
May 17
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
1
+0.0%
|
$1
$1.2 P/Share
|
|
May 16
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
20,620
+33.68%
|
$20,620
$1.18 P/Share
|
|
May 13
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
3,898
+16.32%
|
$3,898
$1.15 P/Share
|
|
May 12
2022
|
Rick Wanstall CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
14,094
+46.69%
|
$14,094
$1.08 P/Share
|
|
Nov 19
2021
|
Theodore Ashburn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,500
+24.65%
|
$32,500
$1.81 P/Share
|
|
Nov 16
2021
|
Stephen Harbin COO and Chief of Staff |
BUY
Open market or private purchase
|
Indirect |
15,000
+50.0%
|
$75,000
$5.78 P/Share
|
|
Nov 16
2021
|
Stephen Harbin COO and Chief of Staff |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$75,000
$5.8 P/Share
|
|
Oct 22
2021
|
Theodore Ashburn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,707
+39.53%
|
$43,707
$1.81 P/Share
|
|
Jun 02
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
10,656
-18.28%
|
$170,496
$16.66 P/Share
|
|
Jun 01
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
12,899
-18.12%
|
$206,384
$16.69 P/Share
|
|
May 24
2021
|
Christophe Queva CSO and SVP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
35,561
+33.31%
|
$35,561
$1.81 P/Share
|
|
Apr 30
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
23,555
-20.33%
|
$376,880
$16.35 P/Share
|
|
Apr 28
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
17,990
-23.31%
|
$269,850
$15.22 P/Share
|
|
Apr 27
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
211
-0.27%
|
$3,165
$15.0 P/Share
|
|
Apr 26
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
54
-0.07%
|
$810
$15.0 P/Share
|
|
Apr 07
2021
|
Theodore Ashburn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,699
+16.88%
|
$23,495
$5.32 P/Share
|
|
Apr 06
2021
|
Christophe Queva CSO and SVP, Research |
SELL
Open market or private sale
|
Direct |
5,300
-6.41%
|
$79,500
$15.01 P/Share
|
|
Feb 17
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
300,000
+8.7%
|
$5,700,000
$19.0 P/Share
|
|
Dec 31
2020
|
Theodore Ashburn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+9.34%
|
$1,900
$1.81 P/Share
|
|
Oct 06
2020
|
Luke Evnin Director |
BUY
Open market or private purchase
|
Indirect |
151,225
+5.72%
|
$2,268,375
$15.0 P/Share
|
|
Oct 06
2020
|
Luke Evnin Director |
BUY
Conversion of derivative security
|
Indirect |
2,225,795
+35.6%
|
-
|
|
Oct 06
2020
|
Ansbert Gadicke > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
325,000
+5.86%
|
$4,875,000
$15.0 P/Share
|
|
Oct 06
2020
|
Ansbert Gadicke > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,785,655
+36.21%
|
-
|
|
Oct 06
2020
|
Spencer Nam Director |
BUY
Conversion of derivative security
|
Direct |
1,924
+50.0%
|
-
|
|
Oct 06
2020
|
Mpm Sun States Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
173,776
+5.75%
|
$2,606,640
$15.0 P/Share
|
|
Oct 06
2020
|
Mpm Sun States Fund, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,559,854
+35.45%
|
-
|
|
Oct 06
2020
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+25.98%
|
$15,000,000
$15.0 P/Share
|
|
Oct 06
2020
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,848,970
+37.9%
|
-
|
|
Oct 06
2020
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
173,776
+5.75%
|
$2,606,640
$15.0 P/Share
|
|
Oct 06
2020
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,559,854
+35.45%
|
-
|
|
Oct 06
2020
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
151,224
+5.98%
|
$2,268,360
$15.0 P/Share
|
|
Oct 06
2020
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,225,801
+36.97%
|
-
|